The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction
The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction After Mastectomy: A Double-Blinded, Randomized Trial
Sponsor: Vanderbilt University Medical Center
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Vanderbilt University Medical Center
- Nephrolithiasis · Phase NA · May 2025
- Parkinson Disease · Dec 2024
- Hypertension · Phase PHASE4 · Dec 2024
- Anxiety · Jun 2024
- Crohn's Disease · Phase PHASE2 · Apr 2024
See all terminations from Vanderbilt University Medical Center
Other Complications trials with similar outcome
This PHASE4 trial investigates Complications and Mastectomy and is currently terminated or withdrawn. Vanderbilt University Medical Center leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
May 2017 — Jun 2018 [monthly]
Terminated PHASE4
▶ Show 1 earlier version
-
Jan 2017 — May 2017 [monthly]
Terminated PHASE4
First recorded
Sep 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Vanderbilt University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .